Pomdoctor receives Nasdaq delisting determination
POMDOCTOR LIMITED said Nasdaq staff determined its shares are subject to delisting after the ADS closing bid price stayed below $1.00 for 30 consecutive business days. The company plans to request a hearing, which would stay any suspension while the appeal is pending.